L ymphatic vessels play an important role in body fluid, as well as immune system homeostasis. To maintain fluid homeostasis, the filtration of fluid and plasma proteins must be balanced by the formation of lymph that is transported into initial lymphatics and eventually returned to the general circulation. Lymph vessels are also the major transporters of soluble antigens and antigen-presenting cells from peripheral tissues to lymph nodes where they mount an immune response. 1 The discovery of lymph vessel growth factors and molecular markers 2 decades ago enabled us to ask new and targeted questions and has led to a dramatic increase in available knowledge in this field.
Malfunctioning or missing lymphatics may result in tissue fluid accumulation and lymphedema that has been studied extensively in experimental models, as well as clinically (for review, see Alitalo 1 and Aspelund et al 2 ) . Less is known, however, on the functional consequences of a chronically expanded lymphatic network. It is well established that many inflammatory conditions result in an expansion of initial lymphatics and lymphatic remodeling 3, 4 and that the lymphangiogenic factor vascular endothelial growth factor (VEGF)-C plays a central role in these processes. In skin, it has been shown that stimulation of lymphangiogenesis by VEGFR-3 or its ligand VEGF-C reduces acute and chronic inflammation, most likely mediated by a stimulation of lymph drainage from the inflamed tissue. [5] [6] [7] In contrast, in models known to stimulate lymphangiogenesis, other groups have shown either no change in clearance 8 or a reduced lymphatic pumping activity, indicating a reduced clearance in acute inflammation. 9, 10 Previous data on the function of an expanded lymphatic network are, therefore, conflicting. In this context, it is pertinent to remember that both components of lymph, fluid and cells, should be taken into account when evaluating lymphatic function. Moreover, interstitial fluid pressure (P if ) is a major determinant of lymph flow, 11 transcapillary fluid balance, and interstitial fluid volume, and this parameter has not been evaluated in a situation with an expanded lymphatic network.
In the present study, we, therefore, aimed to resolve questions related to the function of an expanded lymphatic network discussed earlier or, to state it differently, what lymphangiogenesis achieves. 12 To this end, we applied a transgenic mouse model stably overexpressing human VEGF-C in the skin under the control of the keratin-14 (K14) promoter. 13 This model could be used to ask questions of lymphatic function related to inherent or induced lymphangiogenesis by applying a recently developed optical imaging method to record lymph flow. We found that VEGF-C overexpression did not affect tissue hydration and P if in control situation. Moreover, these parameters were not differently influenced in the 2 strains in acute and chronic inflammation. Hyperplastic lymphatic vessels, however, had increased transport capacity in a situation involving fluid overload not induced by inflammation. These findings imply that the hyperplastic vessels facilitate initial lymph formation and, thus, increase transport rate, provided the absence of inflammatory mediators. Nevertheless, the hyperplastic vessels were not capable of inducing increased immune cell migration in spite of an enhanced production of immune cell chemoattractants.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Lymphatic Vessel Area in the Skin Is Substantially Enlarged in K14-VEGF-C Mice
Our major aim was to resolve questions related to the function of an expanded lymphatic network and, thereby, what is achieved by lymphangiogenesis. 12 To this end, we chose an established transgenic model overexpressing VEGF-C in skin. 13 To confirm that K14-VEGF-C (keratin-14 vascular endothelial growth factor-C) overexpression led to increased lymphangiogenesis, we performed whole-mount staining on wild-type (WT) and K14-VEGF-C ears, costaining with the lymphatic-specific marker LYVE-1 (lymph vessel endothelial hyaluronan receptor-1) and the blood vessel marker CD31. In line with previous studies on K14-VEGF-C mice, we found a much denser ear lymphatic network in K14-VEGF-C than in WT mice ( Figure 1A) , with an ≈100% increase in LYVE-1 + area ( Figure 1B ). On the other hand, the blood vessel network as stained with CD31 in K14-VEGF-C mice appeared normal ( Figure 1A) , and the blood vessel area was not different in the 2 strains ( Figure 1B) . We also assessed the lymph vessels in other regions to study whether the phenotype applied to all skin areas. Serial sections of paw and back skin confirmed a significant increase in LYVE-1 + lymphatic vessel area in K14-VEGF-C mice (Figure 1 C) and, thereby, that this model was suitable for functional studies of lymphangiogenesis.
Lymphatic Drainage and Fluid Balance Parameters Are Similar to WT in K14-VEGF-C Mice in Control Situation and During Inflammation
To assess whether the expanded lymphatic network influenced lymphatic drainage from the skin, we injected 0.5 μL Alexa680-labeled bovine serum albumin into the dermis of the hind paw and followed the washout of tracer by optical imaging over the course of 6 hours. The removal of albumin is restricted exclusively to lymphatics because of its size and will, thus, reflect lymph flow from the injected area. To facilitate lymph flow, the mice were freely moving in their cage in between the hourly imaging sessions. Despite having more lymphatic vessels than WT mice, washout of tracer and, thereby, lymph flow in K14-VEGF-C mice was similar to that of WT (Figure 2A ). The equal lymph flow suggested a similar + blood vessels in ears from wild-type (WT) and K14-VEGF-C mice. Scale bar=200 μm. B, Quantification of lymphatic (left) and blood vessel (right) area in ear skin of WT and K14-VEGF-C mice. Four areas from each ear whole-mount preparation were counted per mouse. The LYVE-1 + lymphatics and CD31 + blood vessels were manually encircled and area calculated in ImageJ. C, Serial sections (10 μm) from intact paw (left) and back skin (right) of WT and K14-VEGF-C mice stained for LYVE-1. LYVE-1 + lymphatic vessels were manually encircled in 3 sections from each mouse and total area per millimeter dermis calculated. Mean±SEM, n=5 to 6. **P<0.01, ***P<0.001, ****P<0.0001. LYVE indicates lymph vessel endothelial hyaluronan receptor-1. lymph production and protein extravasation. We, therefore, assessed the extravasation of radioactively labeled albumin and found the protein extravasation to be not different in the 2 strains in the unperturbed control situation ( Figure 2B ). The similar lymph flow and protein extravasation suggest that the lymph production, that is, transcapillary fluid filtration, is equal in the 2 strains.
The fluid volume parameters and potential drivers of lymph flow, total tissue water, and P if , were also found to be not different from those of WT in K14-VEGF-C mice hind paw ( Figure 3A and 3C) and ear ( Figure 3B and 3D) in control situation. These findings were also reflected in back skin (data not shown). Moreover, systolic and mean arterial blood pressures were similar, averaging 113±5 mm Hg (systolic) and 92±3 mm Hg (mean) in WT (n=11), with corresponding pressures of 114±4 and 92±4 mm Hg in K14-VEGF-C mice (n=10).
We hypothesized that a potential difference in transport capacity of the 2 strains would manifest in skin inflammation known to induce an increase in capillary filtration. To induce inflammation, we used 2 models, one acute based on injection of lipopolysaccharide and one chronic based on topical application of oxazolone that will induce delayed-type hypersensitivity. Seven days after the initial sensitization with 2% oxazolone, and 2 days after challenge (1% oxazolone), we measured lymph flow, P if , and total tissue water. The delayedtype hypersensitivity response resulted in significantly increased total tissue water in paw skin ( Figure 3A ) and ear ( Figure 3B ), as well as P if in corresponding sites ( Figure 3C and 3D), reflecting accumulation of fluid, but to the same extent in both strains.
The observed increase in P if , again a consequence of increased fluid accumulation during inflammation, will represent an increased driving force for filling of initial lymphatics that might promote lymph drainage. 11 We observed, however, that lymph transport was significantly halted in oxazoloneinduced inflammation, resulting in an equally reduced washout rate of ≈15% in both strains when compared with the control situation ( Figure 2C ).
We also induced an acute inflammation by local injection of lipopolysaccharide. Lipopolysaccharide actually resulted in an increase in total tissue water and P if that was even more pronounced than the corresponding responses observed after oxazolone treatment in paw skin ( Figure 3A and 3C), as well as in ear ( Figure 3B and 3D) . Surprisingly, more fluid accumulated in the ear in K14-VEGF-C than in WT ( Figure 3B ) mice, an effect that was not seen in the paw ( Figure 3A ). In spite of an even stronger stimulus for lymph vessel filling, the reduction in lymphatic tracer washout was even more pronounced than in oxazolone-induced inflammation, amounting to 43% in K14-VEGF-C and 38% in WT when compared with respective controls ( Figure 2C ). Moreover, this impeded lymph flow effect was long-lasting, as shown by the observation of close to twice the amount of tracer retained in skin 24 hours after lipopolysaccharide injection in both strains ( Figure 2D ). I-HSA present in the vasculature of the excised tissue at 30 minutes. C, Rate constants (k) calculated by determining the slope of the individual washout curves for WT and K14-VEGF-C mice during basal conditions, after oxazolone-induced hypersensitivity response (day 7) or after intradermal injection of 2 μL lipopolysaccharide (LPS; 4 μg/μL). D, Fraction of counts remaining in the intradermal depot in hind paw of WT and K14-VEGF-C mice 24 hours after injection of a mixture of either 2 μL isotonic saline (control group) or 2 μL LPS (4 μg/μL) both in combination with 1 μL Alexa680-BSA. Mean±SEM, n=6 to 8. *P<0.05, **P<0.01, ****P<0.0001. 
Interstitial Fluid Volume Overload Increases Lymph Flow to a Greater Extent in K14-VEGF-C Mice
As described earlier, we observed no effect of an increased lymph vessel area after induction of lymphangiogenesis after acute as well as chronic inflammation. Inflammation may, however, result in the release of numerous mediators, notably nitric oxide (NO), that can interfere with lymphatic endothelial function and result in lymphatic contractile dysfunction 14 and, thus, counteract the stimulus effect of increased capillary filtration and interstitial fluid volume on lymphatic flow. To separate these effects, we investigated whether there were functional consequences of an expanded lymphatic network in a situation where solely the interstitial volume was increased by assessing lymph flow in the 2 strains after local overhydration. To this end, we injected 30 μL isotonic saline into the dermis of the hind paw with an insulin syringe after an initial control washout period lasting for 120 minutes ( Figure 4A) . In response to the fluid volume overload at 180 minutes, the K14-VEGF-C mice experienced a faster washout of tracer for the following period ≤300 minutes compared with WT ( Figure 4A ), quantified as an increase (more negative) in average rate constant k of 25% in K14-VEGF-C compared with WT mice ( Figure 4B) .
To investigate the local driving pressure for lymph formation, we also assessed P if in the overhydrated skin area. We found that the local P if increased dramatically, from average values of −1 mm Hg in control situation before injection to 7 to 8 mm Hg immediately after injection ( Figure 4C ). Although P if in the K14-VEGF-C mice in the first period after injection (denoted "0" in Figure 4C ) tended to be lower than in WT mice, this difference was not significant (P=0.12). The pressure subsided gradually but was still higher than control pressure 120 minutes after saline injection in both strains. The observed increased lymph transport capacity in K14-VEGF-C mice in spite of a similar (or slightly lower) pressure gradient for lymph vessel filling suggests that the enhanced lymph vessel area in this strain facilitates initial lymph formation compared with the WT mice.
Reduced Effect of Local Interstitial Fluid Overload on Lymph Flow in Chy Mice
To study the effect of lymphatic hypoplasia on local overhydration, we injected 30 μL isotonic saline into hindlimb skin of Chy mice missing initial lymphatic vessels in dermis, resulting in lymphedema. 15 In agreement with previous studies, 16 Chy mice had visible hindlimb edema, lower washout rate, and thus lymph formation and flow than WT mice in control situation before local saline injection ( Figure 5A ). This occurred in spite of an increased P if and, thus, driving pressure for lymph formation ( Figure 5C ), suggesting the initial lymph formation was impeded even in control situation. Intradermal injection of 30 μL isotonic saline into the same hind paw resulted in an apparent immediate, but not significant, increase in washout in the Chy mice ( Figure 5A ). As described earlier, there was, however, an increase in washout in WT mice after this local volume stimulus, maintaining the difference in rate constants (k) between the strains compared with the control situation ( Figure 5B) . Apparently, the increased driving pressure for lymph formation, P if , in control situation ( Figure 5C ) could not counteract the reduction in control lymph flow in Chy. Surprisingly, there was a more pronounced increase in P if in WT than in Chy after local overhydration ( Figure 5C ), but this is likely a result of a faster local fluid volume and pressure dissipation in the Chy hindlimb because of a strongly increased hydraulic conductivity in edema. 17 The observed reduced lymph transport capacity in Chy in spite of an increased pressure gradient for lymph vessel filling in control situation, and a similar gradient >60 minutes after local overhydration, suggests that the reduced lymph vessel area in Chy results in an increased impediment of initial lymph formation compared with WT.
Synthesis of CCL21 Enhanced Without Affecting Migration of Immune Cells From Skin in K14-VEGF-C Mice
Lymphatic vasculature has been shown to be highly dynamic, and lymphatic endothelial cells are producers of chemokines and adhesion molecules that play active roles in inflammatory and immune processes. 3 We asked whether the enhanced area of LYVE-1 + lymphatics shown in K14-VEGF-C mice resulted in an increased content of the chemokine CCL21, known as one of the most central immune cell, notably dendritic cell, attractants in skin. 18 By whole mount staining, we showed the presence of CCL21 in LYVE-1 + initial lymphatics in skin ( Figure 6A ). Interestingly, when CCL21 expression was calculated as percent area per field of view, the expression in the transgenic mice was almost twice that of WT mice ( Figure 6B ), suggesting a higher content of this chemokine in the transgenic mice. The positive staining per lymph vessel area, however, did not differ in K14-VEGF-C and WT mice ( Figure 6C ).
We then tested whether the increased content of CCL21 affected migration of immune cells from skin. First, we assessed the number of dendritic cells determined as CD207 + /major histocompatibility complex (MHC) + cells in ear skin from epidermal sheets and found no difference between the strains during control conditions ( Figure 7A and 7B) . We then induced local inflammation by painting with fluorescein isothiocyanate and recorded the cell uptake in draining lymph nodes by flow cytometry. There was no increased migration of fluorescein isothiocyanate-positive MHCII + CD11c
+ cells neither at 12 hours (data not shown) nor at 18 hours after painting ( Figure 7C ), suggesting that even though there was an enhanced lymph vessel area producing the dendritic cell mobilizing chemokine CCL21 in K14-VEGF-C mice, this had no effect on dendritic cell migration to the draining lymph node. 
Discussion
Whether the formation of new lymphatics, that is, lymphangiogenesis, has functional consequences for lymphatic transport is a controversial issue that was addressed in the present study. To this end, we used a transgenic mouse model expressing VEGF-C in keratinocytes, producing a hyperplastic lymphatic network in skin. Transgenic mice had normal water content, P if , capillary permeability, and lymph flow during control conditions, suggesting a normal capillary barrier. Induction of acute and chronic inflammation reduced lymph flow to an equal extent in transgenic and WT mice. Interestingly, local infusion of fluid in skin stimulated fluid removal more forcefully in the transgenic mice. Such an expanded lymphatic network is capable of enhanced clearance of fluid, possibly because of an increased area that will offer less resistance to fluid uptake and, thus, facilitate initial lymph formation. In spite of an increased production of the dendritic cell mobilizing chemokine CCL21, however, immune cell migration from skin was unchanged. Our data suggest that an expanded lymphatic network is capable of enhanced clearance of fluid, provided that there is an increased interstitial fluid driving pressure for filling of initial lymphatics and that the downstream pumping capacity is not compromised by, for example, an acute inflammation.
Evaluation of Methods
When attempting to understand diverging results derived from various studies on the functional role of lymphatics, a closer analysis of the methods used is pertinent since methodological aspects may explain at least some of this variation. Here we chose an extensively evaluated near-infrared imaging method to assess lymph flow. This method is based on washout of Alexa-680-labeled albumin with a molecular weight of ≈67 kDa and, thus, within the optimal range for tissue clearance through lymph. 16 Moreover, with this technique, the injection volume is low, which will reduce the possibility of an increase in local P if that per se will contribute to an increased filling pressure of lymphatics and, thereby, artificially enhanced lymph flow. The imaging probe is also stable and without any free dye. Thereby, unspecific binding to proteins in the tissue and clearance of free dye to plasma is not a problem, as might be expected with, for example, Evans blue and Indocyanin green. 19, 20 Although well suited for paw and back skin, we experienced problems with exact positioning and tissue photon absorption when imaging the ear, resulting in variable count recovery and nonlinear washout curves. Although the ear is a frequently used site for studies of skin fluid homeostasis, we, therefore, chose paw skin as our preferential area of study. We also chose the micropipette method for measurement of P if that is practically atraumatic and does not add to or remove fluid from the tissue to minimize trauma and fluid volume artifacts.
Comparison to Previous Studies
The conspicuous change in lymphatic vessel area in the K14-VEGF-C mouse model had no obvious transcapillary fluid exchange phenotype in control situation; the protein extravasation, P if , and tissue water content were not different from that in WT mice. Because these parameters were not different, it is to be expected that the lymph flow is not different, as actually observed. In contrast, Huggenberger et al 5 found an increased skin lymph flow in the K14-VEGF-C model based on clearance of Evans blue, a tracer that is not well suited for quantification of lymph flow as discussed earlier. Moreover, an increase was also found in a recent study based on tissue clearance of near-infrared tracer. 21 In light of several previous observations of an increased clearance of tissue fluid in closely related models, [5] [6] [7] [8] it was surprising that we actually found a similarly reduced lymph flow in K14-VEGF-C and WT mice in 2 different models of skin inflammation, that is, there was no lymph flow effect of enhanced lymphangiogenesis. This occurred in spite of an increased amount of tissue water and a higher P if that should both act as a driving force for increased lymph formation and flow. 11, 22 Still, a reduced lymph pumping has been shown in many types of inflammation as recently summarized by Scallan et al, 14 notably in acute inflammation induced by lipopolysaccharide, 23 as well as in delayed-type hypersensitivity induced by oxazolone, 10 as used here. Release of NO will inhibit lymphatic tone and spontaneous contractions, 14 and it is likely that iNOS (inducible nitric oxide synthase), shown to be released by immune cells locally in inflamed tissue, 10 contributed to the reduced lymph flow seen in both our inflammation models. There are several factors that may explain discrepancies between our and previous data. One of these is variation of iNOS expression between mouse strains, 14 and other factors are the methods used to assess lymph flow as discussed earlier.
Because initial lymphatics also take up and transport immune cells to draining lymph nodes where they influence the immune response, we also assessed dendritic cells in skin and their ability to migrate to draining lymph nodes after stimulation with fluorescein isothiocyanate. The dendritic cell numbers, as well as their migration, were unaffected by strain, in spite of a markedly increased level of the lymphoid homing cytokine CCL21 in the K14-VEGF-C mice. Apparently, the increased lymphatic vessel area is capable of augmenting the production and, thereby, the gradient of chemoattractants, but this is not sufficient to mobilize tissue-resident immune cells to initial lymphatics. The reason might be downregulation of the CC chemokine receptor 7 for which CCL21 serves as a ligand on dendritic cells that may occur in VEGF-C overexpressing mice. 21 It should be noted, though, that our findings are a result of VEGF-C overexpression only and that the situation may be different in more complex models where the lymphangiogenesis is induced by inflammation. 4 
Mechanism for Lymph Formation
To our knowledge, all previous studies on the K14-VEGF-C model have used interventions involving inflammation. As discussed earlier, inflammatory reactions will result in capillary hyperfiltration, fluid extravasation, and thereby increased tissue fluid content. Accumulated fluid will result in an increased P if , and together, these parameters will stimulate filling of the initial lymphatics and fluid transport. In inflammation, this picture is complicated by the fact that several inflammatory mediators, notably NO, have an inhibitory effect on collecting vessel pumping, thereby, counteracting the effect of increased volume and pressure. The tipping of the balance in one or the other direction may explain the diverging results discussed earlier. To avoid the influence of inflammation, we injected fluid directly intradermally and could, thereby, show that the expanded lymphatic network was actually capable of an enhanced lymphatic fluid transport that was driven by a local increase in volume and P if . Clearly, the hyperplastic network of initial lymphatics deriving from overexpression of VEGF-C resulted in a strongly enhanced lymphatic vessel area that will enhance the fluid uptake and accordingly lymph transport in response to pressure gradients. Lymph flow might have been influenced by a difference in structure and, thus, resistance in downstream lymph nodes, but that is not likely because of our finding of similar structure and area of lymph node sinusoids in K14-VEGF-C and WT mice. 24 The fact that the lymph flow was higher in transgenic than in WT mice for the same P if gradient suggests that lymphangiogenesis results in reduced resistance against lymph formation.
VEGF-C Gene Therapy: Clinical Implications
The present study shows the importance of a functional evaluation of a morphological phenotype resulting from genetic modifications and may have implications for therapy of lymphatic disorders. The lack of effects when inducing inflammation likely reflects that lymph drainage can be modulated downstream of the initial lymphatics, as discussed earlier.
Additional knowledge on such downstream mechanisms is needed when considering the potential benefits of VEGF-C-induced lymphangiogenesis in humans. Our findings of facilitated initial lymph formation and enhanced chemokine production after lymphangiogenesis may explain the previously observed favorable effects of VEGF-C in inflammatory edema and lymphedema therapy. Karkkainen et al 15 used adenovirus-mediated VEGF-C gene therapy and could generate functional lymphatic vessels that reduced swelling in a mouse model of primary lymphedema. Transgenic overexpression of VEGF-C moreover inhibited chronic skin inflammation and reduced edema in a mouse model 6 and attenuated joint tissue damage. 25 In addition, VEGF-C treatment has been shown to be important in forming both afferent and efferent connections with the preexisting lymphatic vessel network and to result in improved postoperative lymph drainage and enhanced survival and functionality of transferred lymph nodes, suggesting that VEGF-C therapy may be beneficial to counteract postoperative lymphedema. 26 It has been suggested that VEGF-C might act as an endogenous counter-regulatory mechanism for limiting edema formation and inflammation, 6 but facilitated initial lymph formation and enhanced chemoattractant production by lymphatics as shown here is a potential common explanation for the therapeutic effect. 
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